Tehran University of Medical Sciences

Science Communicator Platform

Share By
Retraction Notice to Non-Invasive Stemi-Related Biomarkers Based on Meta-Analysis and Gene Prioritization [Computers in Biology and Medicine 161 (2023) 106997] Publisher Pubmed

Summary: Why was a paper retracted? A publisher review cited unresolved integrity concerns and withdrew the article; the authors dispute the decision. #Retraction #ResearchIntegrity

Goharrizi M A S B ; Ghodsi S ; Mokhtari M ; Moravveji S S
Authors

Source: Computers in Biology and Medicine Published:2026


Abstract

This article has been retracted: please see Elsevier Policy on Article Correction, Retraction and Removal (https://www.elsevier.com/about/policies/article-withdrawal). This article is being retracted at the request of an impartial field expert acting in the role of an independent Publishing Ethics advisor. Post-publication, an investigation was conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team with guidance from the Independent Publishing Ethics Advisor. This investigation found that the article duplicates significant parts of a paper that had already appeared in Exp Eye Res. 2021 Apr. 205. 108451. https://doi.org/10.1016/j.exer.2021.108451 and Iran J Allergy Asthma Immunol. 2017 Oct;16(5):396-403, PMID: 29149779. One of the conditions of submission of a paper for publication is that authors declare explicitly that the paper has not been previously published and is not under consideration for publication elsewhere. Re-use of any data should be appropriately cited. Elsevier's Research Integrity & Publishing Ethics team reached out to the authors for an explanation, but they failed to provide a satisfactory explanation. Having reviewed the findings of Elsevier's Research Integrity & Publishing Ethics team, the Independent Publishing Ethics Advisor has lost confidence in the integrity of the article and has determined it should be retracted. Apologies are offered to readers of the journal that this was not detected during the submission process. The authors disagree with the retraction and dispute the grounds for it. © 2026 Elsevier Ltd.
Related Docs
View other Related Docs
1. Retraction Notice to Vascular Endothelial Growth Factor (Vegf) Delivery Approaches in Regenerative Medicine(Biomedicine & Pharmacotherapy, (2023), 166, C, (115301), (S0753332223010922), 10.1016/J.Biopha.2023.115301), Biomedicine and Pharmacotherapy (2026)
2. Retraction Notice to Vertical Distribution of Ambient Air Pollutants (Pm2.5, Pm10, Nox, and No2); a Systematic Review(Heliyon, (2024), 10, 21, (E39726), (S240584402415757x), 10.1016/J.Heliyon.2024.E39726), Heliyon (2026)
3. Retraction Notice to Angioregulatory Role of Mirnas and Exosomal Mirnas in Glioblastoma Pathogenesis(Biomedicine & Pharmacotherapy, (2022), 148, C, (112760), (S0753332222001482), 10.1016/J.Biopha.2022.112760), Biomedicine and Pharmacotherapy (2026)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (3)
Fatameh Mottaghitalab (1)
Other Related Docs
4. Retraction Notice to Recent Advances in Glioblastoma Multiforme Therapy: A Focus on Autophagy Regulation(Biomedicine & Pharmacotherapy, (2022), 155, C, (113740), (S0753332222011295), 10.1016/J.Biopha.2022.113740), Biomedicine and Pharmacotherapy (2026)
5. Retracted: Evaluation of the Effect of Omega-3 Fatty Acids in the Treatment of Premenstrual Syndrome: A Pilot Trial (Complementary Therapies in Medicine (2013) 21(3) (141–146), (S0965229912001744), (10.1016/J.Ctim.2012.12.008)), Complementary Therapies in Medicine (2023)
6. Retraction Notice to “Recent Advances in Cardiac Regeneration: Stem Cell, Biomaterial and Growth Factors” [Biomed. Pharmacother. 87 (2017) 37–45](S0753332216316316)(10.1016/J.Biopha.2016.12.071), Biomedicine and Pharmacotherapy (2017)
7. Retraction Notice to “Silencing of P68 and Stat3 Synergistically Diminishes Cancer Progression” [Life Sci. 249 (2020) 117499] (Life Sciences (2020) 249, (S0024320520302472), (10.1016/J.Lfs.2020.117499)), Life Sciences (2024)
8. Retraction Notice to “How Micrornas Affect the Pd-L1 and Its Synthetic Pathway in Cancer” [Int. Immunopharmacol. 84 (2020) 106594], International Immunopharmacology (2025)
9. Retraction Notice to Adult Hippocampal Neurogenesis (Ahn) Controls Central Nervous System and Promotes Peripheral Nervous System Regeneration Via Physical Exercise(Biomedicine & Pharmacotherapy, (2023), 165, C, (115078), (S0753332223008697), 10.1016/J.Biopha.2023.115078), Biomedicine and Pharmacotherapy (2026)
10. Retraction Notice to “Inhibition of Cd73 Using Folate Targeted Nanoparticles Carrying Anti-Cd73 Sirna Potentiates Anticancer Efficacy of Dinaciclib” [Life Sci. 259 (2020) 118150] (Life Sciences (2020) 259, (S0024320520309024), (10.1016/J.Lfs.2020.118150)), Life Sciences (2024)
11. Retraction Notice to “The Significance of Essential Oils and Their Antifungal Properties in the Food Industry: A Systematic Review” [Heliyon 9 (2023) E21386](S2405844023085948)(10.1016/J.Heliyon.2023.E21386), Heliyon (2025)
12. Retraction Notice to “Possible Involvement of Creb/Bdnf Signaling Pathway in Neuroprotective Effects of Topiramate Against Methylphenidate Induced Apoptosis, Oxidative Stress and Inflammation in Hippocampus of Rats: Molecular, Biochemical and Histological Evidences” [Brain. Res. Bull. 132 (2017) 82–98, (S0361923016302763), (10.1016/J.Brainresbull.2017.05.011)], Brain Research Bulletin (2024)
13. Retraction Notice to “Selective Mapping of Brain Cox-1 With [11 C]Ps13: Pharmacokinetic Evidence From Human Pet Imaging” [Ibro Neurosci. Rep. 18 (2025) 657–662, (S2667242125000594), (10.1016/J.Ibneur.2025.04.012)], IBRO Neuroscience Reports (2026)
14. Retraction Notice to “Therapeutic Role of Enoxaparin in Intra-Uterine Growth Restriction: A Randomized Clinical Trial” [J Gynecol Obstet Hum Reprod (2021) 102070](S246878472100012x)(10.1016/J.Jogoh.2021.102070), Journal of Gynecology Obstetrics and Human Reproduction (2025)
15. Retraction Notice to “Serum Level of Pcbs and Ocps and Leukocyte Telomere Length Among Adults in Tehran, Iran” [Chemosphere 248, June 2020, 126092], Chemosphere (2025)
16. Retraction Notice to “Analysis of Conocurvone, Ganoderic Acid a and Oleuropein Molecules Against the Main Protease Molecule of Covid-19 by in Silico Approaches: Molecular Dynamics Docking Studies” [Engineering Analysis With Boundary Elements Volume 150 (2023) Pages 583-598, (S0955799723001005), (10.1016/J.Enganabound.2023.02.043)], Engineering Analysis with Boundary Elements (2023)
17. Retraction Notice to Resveratrol Inhibited Colorectal Cancer Progression by Reducing Oxidative Dna Damage by Targeting the Jnk Signaling Pathway (Heliyon, (2024), 10, 21, (E38631), (S2405844024146622), 10.1016/J.Heliyon.2024.E38631), Heliyon (2025)
18. Retraction Notice to “Theranostic Silk Sericin/Spion Nanoparticles for Targeted Delivery of Ror1 Sirna: Synthesis, Characterization, Diagnosis and Anticancer Effect on Triple-Negative Breast Cancer” [Int. J. Biol. Macromol. 221 (2022) 604–612], International Journal of Biological Macromolecules (2026)
19. Retraction Notice to “Highly Antifouling Polymer-Nanoparticle-Nanoparticle/Polymer Hybrid Membranes” [Sci. Total Environ. 810 (2022) / 152228] (Science of the Total Environment (2022) 810, (S0048969721073046), (10.1016/J.Scitotenv.2021.152228)), Science of the Total Environment (2026)
20. Retraction Notice to “Application of Ag Nanoparticles Decorated on Graphene Nanosheets for Electrochemical Sensing of Cea As an Important Cancer Biomarker” [Environ. Res. 239 (2023) 117363] (Environmental Research (2023) 239(P2), (S0013935123021679), (10.1016/J.Envres.2023.117363)), Environmental Research (2026)